Physicians can discuss the pros and cons of medicinal marijuana with their patients without worry of the Drug Enforcement Administration cracking down on them, a federal appeals court ruled in October. A three-judge panel of the 9th U.S. Circuit Court of Appeals in San Francisco unanimously ruled that a 1996 federal policy that said physicians could lose their DEA numbers if they discussed the issue tramples on First Amendment rights that allow a doctor and patient to discuss medical issues. The policy had some physicians fearful of discussing the issue with patients who have cancer, AIDS or other debilitating diseases...